Accessibility StatementSkip Navigation Chief Digital & Analytics Officer Katya Andresen to lead Excellence & Transformation Initiatives BLOOMFIELD, Conn., Nov. 6, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today announced that Dr. Amy Flaster has been named Chief Medical Officer of The Cigna Group, effective November 1. Dr. Flaster, who joined the company last year as Chief Medical Officer of Cigna Healthcare, will now serve in an expanded enterprise role across both Cigna Healthc ...

Cigna Group's Strategic Moves Amid Market ChallengesCigna Group (NYSE: CI) is a global health services company that provides a wide range of insurance products and services. It operates through segments like Evernorth, which focuses on health services, and Cigna Healthcare, which offers insurance products. Cigna competes with other major health insurers like UnitedHealth Group and Anthem.On November 5, 2025, Wells Fargo set a price target of $300 for CI, while the stock was trading at $264.66. This target s ...

Goldman Sachs analyst Scott Fidel lowered the firm’s price target on Cigna (CI) to $330 from $370 and keeps a Buy rating on the shares. Cigna shares fell 18% after management disclosed major structural changes to the Evernorth PBM business, signaling margin compression beginning in 2026, the analyst tells investors in a research note. The decline reflects investor surprise over earlier-than-expected margin resets tied to a new rebate-free pricing model and lower-margin renewals with key clients representin ...

公司高管持股变动 - 董事长兼首席执行官Cordani David于2025年11月3日以每股24188美元的价格增持了4134股公司普通股 [1] - 此次增持使其总持股数达到157935股 [1] 公司近期财务表现与市场反应 - 公司2025年第三季度财报后股价出现显著下跌 跌幅达17% [2] - 股价下跌主要由于公司披露其药房福利服务业务在未来两年将面临利润率压力 [2] - 尽管股价下跌 公司当季利润和收入均实现增长 主要得益于Evernorth部门的增长 [2] - 股价近期出现反弹 当前价格为25312美元 单日上涨356% 当日交易区间为23951美元至25348美元 [4] - 过去一年中 股价波动区间为23951美元至350美元 公司当前市值约为676亿美元 [4] 公司战略与业务调整 - 为应对成本问题 Evernorth部门推出免回扣药房福利模式 旨在降低成本 [3] - 该模式将于2027年起应用于Cigna Healthcare的全保险人群 并于2028年成为所有Evernorth药房福利客户的标准模式 [3] - 此举是公司改善政府项目合作伙伴经济条款战略的一部分 [3] - 公司积极应对财务压力并提升透明度 体现了对长期战略客户的承诺 [5] - 公司努力适应行业挑战并维持药房福利业务增长 展现了在竞争市场中的韧性 [5]

Cigna Group (NYSE:CI) stock plunged after the company, during its third-quarter 2025 earnings call, said it expects margin pressure within the pharmacy benefit services segment over the next two years.CI stock is showing notable weakness. View the charts hereOn Monday, Evernorth, Cigna’s health services division, announced a new rebate-free pharmacy benefit model designed to lower costs and improve transparency.Cigna Healthcare will adopt this model for its fully insured lives beginning in 2027. It will bec ...

Key Takeaways Cigna's Q3 EPS of $7.83 beat estimates and rose 4% year over year on strong segment performance.Evernorth Health Services revenues jumped 15% to $60.4B, led by new business and client expansion.Cigna Healthcare sales fell 18% after divestitures to HCSC, weighing on medical membership and margins.The Cigna Group (CI) reported third-quarter 2025 adjusted earnings per share (EPS) of $7.83, which beat the Zacks Consensus Estimate by 1.7%. The bottom line advanced 4% year over year.Adjusted revenue ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-38769 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 82-4991898 (State or other jurisdicti ...

Shares of Cigna Group (CI) tumbled 17% on Thursday after the health insurer warned that profit margins in its pharmacy-benefit-services division are expected to decline over the next two years. The an... ...

财务业绩概览 - 公司2025年第三季度营收为695.7亿美元，同比增长9.2% [1] - 季度每股收益为7.83美元，高于去年同期的7.51美元 [1] - 营收超出市场共识预期671.6亿美元，实现3.59%的惊喜 [1] - 每股收益超出市场共识预期7.70美元，实现1.69%的惊喜 [1] 关键运营指标表现 - 信诺医疗的医疗护理比率（Medical Care Ratio）为84.8%，高于分析师平均预估的84.2% [4] - 药房索赔量达5.58亿次，高于分析师预估的5.466亿次 [4] - 国际健康业务的医疗客户覆盖人数为171万，略高于分析师预估的170万 [4] - 总医疗客户覆盖人数为1806万，与分析师的预估完全一致 [4] 各业务板块收入分析 - Evernorth健康服务业务收入为603.9亿美元，同比增长15.1%，并超出分析师预估的571.7亿美元 [4] - 药房业务收入为560.5亿美元，同比增长16.1%，超出分析师预估的531.4亿美元 [4] - 费用及其他收入为43.8亿美元，同比增长12.6%，超出分析师预估的42.9亿美元 [4] - 净投资收入为2.33亿美元，同比大幅增长174.1%，但低于分析师预估的2.4597亿美元 [4] - 信诺医疗业务收入为109.3亿美元，同比下降18%，与分析师的109.5亿美元预估基本持平 [4] - 保费收入为90.8亿美元，同比下降20.6%，略高于分析师预估的90.3亿美元 [4] 细分保费收入 - 信诺医疗的保费收入为89.4亿美元，同比下降20.9%，与分析师的90亿美元预估基本一致 [4] - 美国商业自留停损保费收入为19.1亿美元，同比增长13%，与分析师的19.2亿美元预估基本一致 [4] 股价表现与市场比较 - 公司股价在过去一个月上涨2.6%，同期标普500指数上涨3.6% [3] - 公司股票目前被列为第三级（持有），预示其近期表现可能与整体市场同步 [3]